Infectious Agents and Cancer

Papers
(The TQCC of Infectious Agents and Cancer is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses49
The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review44
Inhibitory effect and mechanism of Lactobacillus crispatus on cervical precancerous cells Ect1/E6E7 and screening of early warning factors39
Validation in Zambia of a cervical screening strategy including HPV genotyping and artificial intelligence (AI)-based automated visual evaluation33
Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status33
Why so much uncertainty about adjuvant HPV vaccines after local treatment? Can the discrepancy between the positive statistical results and the scientific community doubts be solved?32
Analysis of the triage value of multigene methylation testing for CIN2 + in hrHPV-positive patients31
Correction: A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China28
Plasma Epstein-Barr virus DNA for the prediction of treatment response and disease progression in non-keratinizing differentiated nasopharyngeal carcinoma28
Precision therapeutic targets for HPV-positive cancers: an overview and new insights27
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis27
Evaluation of enterotoxigenic Bacteroides fragilis correlation with the expression of cellular signaling pathway genes in Iranian patients with colorectal cancer23
The effectiveness of a model-based health education program on genital warts preventive behaviors: a quasi-experimental study22
Strategies to evaluate outcomes in long-COVID-19 and post-COVID survivors22
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study21
Catching viral breast cancer21
Cox proportional hazard-model application: time to cervical cancer screening among women living with HIV in South Africa20
Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 20
Circular RNA circRHOBTB3 is downregulated in hepatocellular carcinoma and suppresses cell proliferation by inhibiting miR-18a maturation19
Highly sensitive deep panel sequencing of 27 HPV genotypes in prostate cancer biopsies results in very low detection rates and indicates that HPV is not a major etiological driver of this malignancy18
Prevalence of HPV in anal cancer: exploring the role of infection and inflammation18
Development and validation of a multiplex qPCR method for identification of high-risk genotypes of human papillomavirus17
Correction: Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases17
Emerging role of microbiota derived outer membrane vesicles to preventive, therapeutic and diagnostic proposes16
Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis15
Risk of cervical intraepithelial neoplasia grade 3 or higher (CIN3+) among women with HPV-test in 1990–1992, a 30-year follow-up study14
Conventional therapy for genital herpesvirus and remission of HPV-related lesions: a case series14
CTSG may inhibit disease progression in HIV-related lung cancer patients by affecting immunosuppression14
Chlamydia pneumoniae infections and development of lung cancer: systematic review14
Correction: Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics14
A comparative analysis of somatic mutational profiles according to HIV status among women with cervical intraepithelial neoplasia 3 (CIN3): a focus on hotspots in TP53, PIK3CA, PTEN, and EGFR13
Polygenic risk scores for cervical HPV infection, neoplasia and cancer show potential for personalised screening: comparison of two methods13
The viral origins of breast cancer13
An overview of mouse models of hepatocellular carcinoma13
Low frequency of HPV positivity in breast tumors among patients from south-central Poland12
Assessing the risk of high-grade squamous intraepithelial lesions (HSIL+) in women with LSIL biopsies: a machine learning-based study12
The trend of schistosomiasis related bladder cancer in the lake zone, Tanzania: a retrospective review over 10 years period12
Primary seminal vesicle Burkitt lymphoma in a patient living with HIV undergoing radical prostate and seminal vesicle resection: a rare missed case report12
Multiple pathogens and prostate cancer12
Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer11
A SEER-based analysis of trends in HPV-associated oropharyngeal squamous cell carcinoma11
Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation11
Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran11
Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial11
Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study11
Correction: Utilization of cervical cancer screening services and its associated factors in Iran: a case–control study10
Undifferentiated carcinoma of the liver with osteoclast-like giant cells: a case report and literature review10
Impact of plasma Epstein–Barr virus DNA in posttreatment nasopharyngeal carcinoma patients after SARS-CoV-2 infection10
Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana10
Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women9
Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer9
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-39
Correction: HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study9
Analyses of Kaposi Sarcoma trends among adults establishing initial outpatient HIV care in Nigeria: 2006–20179
Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials8
Microbiota and metabolite profiles of saliva, oral swab and cancer tissue from patients with oral squamous cell carcinoma (OSCC)8
Outcome in patients with HIV-associated Hodgkin lymphoma treated with chemotherapy using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the combination antiretroviral therapy (cART) era: resu8
Molecular triage of cervical screening samples in women 55–59 years of age: a pilot study8
Seroprevalence of human papilloma virus 6, 11, 16 and 18 among pregnant women in Mwanza-Tanzania8
CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance7
Tumor-infiltrating CD4+ CD25+ FOXP3+ Treg is associated with plasma EBV DNA and disease progression in nasopharyngeal carcinoma7
High-risk HPV genotypes in women with abnormal cytology: a 12-year retrospective study7
High-risk human papillomavirus genotyping in cervical cancers in Tanzania7
Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma7
HPV16 E6 enhances the radiosensitivity in HPV-positive human head and neck squamous cell carcinoma by regulating the miR-27a-3p/SMG1 axis7
Real-world clinical features and survival outcomes in diffuse large B-cell lymphoma patients with hepatitis B virus infection7
Prevalence and characteristics of mouse mammary tumor virus-like virus associated breast cancer in China7
Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites7
Impact of Epstein-Barr virus and CD lymphocytes on the prognosis of patients with advanced nasopharyngeal carcinoma7
Presence of a mouse mammary tumour virus-like in feline lymphomas: a preliminary study7
An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infecti6
Distribution patterns of human papillomavirus genotypes among women in Guangzhou, China6
Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded6
Prevalence of blood stream infections and associated factors among febrile neutropenic cancer patients on chemotherapy at Ocean Road Cancer Institute, Tanzania6
Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic6
Willingness to accept human papilloma virus vaccination and its associated factors among parents with eligible daughters in Addis Zemen town, Northwest Ethiopia6
The epidemic of human papillomavirus virus-related oropharyngeal cancer: current controversies and future questions6
Nelfinavir inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly6
Pneumocystis jirovecii with high probability detected in bronchoalveolar lavage fluid of chemotherapy-related interstitial pneumonia in patients with lymphoma using metagenomic next-generation sequenc6
High-risk human papillomavirus genotype distribution among women with gynecology complaints in northwest Ethiopia6
Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation6
0.1416609287262